Editas Medicine (EDIT) Reports Q4 Loss of $0.52/Share

Editas Medicine (NASDAQ: EDIT) reported Q4 EPS of ($0.52), versus ($0.84) reported last year.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates